Therefore, we hypothesized that the activation of CXCR1/2 may have a detrimental role in the insulin sensitivity, thus inducing resistance and its inhibition may have positive effects on improving insulin sensitivity and preventing or treating metabolic disorders such as diabetes mellitus. Here, INS is linked to metabolic disease.